CAS: 3569-99-1; N-(Hydroxymethyl)-3-Pyridinecarboxamide

相似化合物

114-33-0 6265-73-2 583-08-4

上下游产品

CAS号100-54-9 3-氰基吡啶 | CAS号50-00-0 甲醛 | CAS号98-92-0 烟酰胺 | CAS号50-00-0 甲醛 | CAS号98-92-0 烟酰胺 | CAS号100-54-9 3-氰基吡啶 | CAS号91026-38-9 N-[(2-hydroxyna...

烟酰胺 反应生成 N-羟甲基烟酰胺
参考文献:Cousse,H.;Mouzin,G.;Rieu,J.-P.;Delhon,A.
标题:Cousse,H.;Mouzin,G.;Rieu,J.-P.;Delhon,A.

专利信息

专利号:WO-2023183781-A2
优先权日:2022-03-20
标 题:Legionaminic acid glycosyltransferases for chemoenzymatic synthesis of glycans and glycoconjugates

专利号:US-4436912-A
优先权日:1981-09-08
标题:7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor
发明人：WHEELER WILLIAM J
权利人:LILLY CO ELI
摘要:Cephalosporin broad spectrum antibiotics possessing a 7 beta -[2-[(2-aminooxazol)-4-yl]-2-(substituted oximino]acetamido side chain and a variety of substituents at the 3-position of the cephalosporins are claimed. Also claimed are intermediates in the synthesis of the above cephalosporin antibiotics.

专利号:US-2016311851-A1
优先权日:2015-04-22
标题 :Methods for the synthesis of ceragenins

专利号:US-4430499-A
优先权日:1981-09-08
标题:7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
发明人：WHEELER WILLIAM J
权利人:LILLY CO ELI
摘要:Cephalosporin broad spectrum antibiotics possessing a 7 beta -[2-[(2-aminooxazol)-4-yl]-2-(substituted oximino)acetamido side chain and a variety of substituents at the 3-position of the cephalosporins are claimed. Also claimed are intermediates in the synthesis of the above cephalosorin antibiotics.

专利号:US-8361516-B2
优先权日:2006-08-03
标 题:Composition comprising sarsasapogenin
发明人：LINTNER KARL; MAS CHAMBERLIN CLAIRE
权利人:SEDERMA SA; LINTNER KARL; MAS CHAMBERLIN CLAIRE
摘要:The présent invention relates to a composition comprising sarsasapogenin or a plant extract containing it in order to improve the gêneral state of the skin and in particular to improve and/or embellish any part of the body showing a déficit in lipids. More particularly, the invention is directed to a cosmetic method to improve the figure, comprising the step of topically applying to the skin a cosmetic or dermopharmaceutical composition comprising sarsasapogenin to favour the expansion and/or the formation of the subcutaneous adipose tissue, and/or to favour the lipid synthesis in the epidermis.